Table I.
Baseline characteristics comparison
| Variables | Overall (n = 255) | GG (n = 183) | GA (n = 63) | AA (n = 9) | P-value |
|---|---|---|---|---|---|
| Age [years] | 57.5 ±14.9 | 56.3 ±12.4 | 58.9 ±14.8 | 57.1 ±13.6 | 0.169 |
| Male, n (%) | 146 (57.3) | 103 (56.3) | 37 (58.7) | 6 (66.7) | 0.024 |
| Current smoker, n (%) | 92 (36.1) | 68 (37.2) | 21 (33.3) | 3 (33.3) | 0.094 |
| Body mass index [kg/m2] | 24.8 ±5.6 | 25.7 ±5.9 | 24.4 ±5.0 | 24.7 ±5.3 | 0.307 |
| Systolic BP [mm Hg] | 134 ±19 | 137 ±23 | 135 ±20 | 132 ±16 | 0.225 |
| Diastolic BP [mm Hg] | 73 ±15 | 77 ±19 | 75 ±16 | 71 ±12 | 0.163 |
| Heart rate [beat per minute] | 79 ±17 | 77 ±16 | 82 ±19 | 78 ±14 | 0.104 |
| Hypertension, n (%) | 169 (66.3) | 122 (66.7) | 41 (65.1) | 6 (66.7) | 0.413 |
| Diabetes mellitus, n (%) | 102 (40) | 72 (39.3) | 26 (41.3) | 4 (44.4) | 0.115 |
| Dyslipidemia, n (%) | 118 (46.3) | 85 (46.4) | 30 (47.6) | 3 (33.3) | 0.052 |
| Hemoglobin [g/l] | 13.4 ±1.8 | 13.8 ±1.5 | 13.2 ±1.2 | 13.5 ±1.9 | 0.268 |
| Platelet [× 109/l] | 196 ±43 | 190 ±52 | 194 ±41 | 203 ±48 | 0.190 |
| Glycated hemoglobin (%) | 6.3 ±1.1 | 6.5 ±1.4 | 6.1 ±1.2 | 6.3 ±1.0 | 0.103 |
| Total cholesterol [mmol/l] | 5.1 ±0.8 | 5.2 ±0.9 | 5.1 ±0.6 | 5.0 ±0.7 | 0.402 |
| Triglyceride [mmol/l] | 1.8 (0.9–3.4) | 1.8 (0.8–3.3) | 1.7 (0.9–3.7) | 1.8 (0.8–3.2) | 0.332 |
| Creatinine [μmol/l] | 72.4 ±12.7 | 73.6 ±12.2 | 72.3 ±12.9 | 71.6 ±12.4 | 0.137 |
| eGFR [ml/min/1.73 m2] | 84.6 ±13.5 | 83.4 ±13.2 | 84.9 ±13.5 | 85.2 ±14.1 | 0.263 |
| Stable angina, n (%) | 147 (57.7) | 106 (57.9) | 36 (57.1) | 5 (55.6) | 0.449 |
| Acute coronary syndrome, n (%) | 108 (42.3) | 80 (43.7) | 24 (38.1) | 4 (44.4) | 0.074 |
| Aspirin, n (%) | 189 (74.1) | 135 (73.8) | 47 (74.6) | 7 (77.8) | 0.128 |
| Clopidogrel, n (%) | 46 (18) | 33 (18) | 11 (17.5) | 2 (22.2) | 0.175 |
| Statins, n (%) | 168 (65.9) | 122 (66.7) | 40 (63.5) | 6 (66.7) | 0.392 |
| Anti-hypertension, n (%) | 157 (61.6) | 111 (60.6) | 40 (63.5) | 6 (66.7) | 0.071 |
| Anti-diabetes, n (%) | 94 (36.9) | 68 (37.2) | 23 (36.5) | 3 (33.3) | 0.093 |
| Proton pump inhibitor, n (%) | 30 (11.8) | 22 (12) | 7 (11.1) | 1 (11.1) | 0.281 |
| Stent number | 1.4 ±0.7 | 1.6 ±0.6 | 1.4 ±0.6 | 1.3 ±0.5 | 0.372 |
| Stent diameter [mm] | 2.65 ±0.43 | 2.67 ±0.41 | 2.62 ±0.35 | 2.64 ±0.39 | 0.631 |
| Stent length [mm] | 25.4 ±5.6 | 25.5 ±6.1 | 25.6 ±5.2 | 25.2 ±4.7 | 0.207 |
Expressed as median and interquartile range; BP – blood pressure, eGFR – estimated glomerular filtration rate.